Your browser is no longer supported. Please, upgrade your browser.
Settings
BLFS BioLife Solutions, Inc. daily Stock Chart
BLFS [NASD]
BioLife Solutions, Inc.
Index- P/E204.59 EPS (ttm)0.13 Insider Own1.90% Shs Outstand23.29M Perf Week14.47%
Market Cap862.56M Forward P/E157.28 EPS next Y0.17 Insider Trans109.25% Shs Float19.04M Perf Month39.47%
Income3.00M PEG20.46 EPS next Q-0.02 Inst Own48.90% Short Float6.60% Perf Quarter67.45%
Sales37.00M P/S23.31 EPS this Y94.50% Inst Trans19.33% Short Ratio3.65 Perf Half Y198.36%
Book/sh4.54 P/B5.99 EPS next Y-40.96% ROA3.10% Target Price26.08 Perf Year30.69%
Cash/sh- P/C- EPS next 5Y10.00% ROE4.10% 52W Range7.37 - 28.28 Perf YTD68.17%
Dividend- P/FCF200.59 EPS past 5Y22.70% ROI26.30% 52W High-3.78% Beta1.54
Dividend %- Quick Ratio4.70 Sales past 5Y34.60% Gross Margin61.50% 52W Low269.20% ATR1.49
Employees151 Current Ratio6.20 Sales Q/Q47.80% Oper. Margin24.10% RSI (14)68.90 Volatility7.71% 5.71%
OptionableYes Debt/Eq0.00 EPS Q/Q-505.90% Profit Margin8.10% Rel Volume5.76 Prev Close25.43
ShortableYes LT Debt/Eq0.00 EarningsAug 06 AMC Payout0.00% Avg Volume344.13K Price27.21
Recom1.90 SMA2020.04% SMA5029.59% SMA20071.28% Volume1,982,822 Change7.00%
Sep-18-20Initiated Cowen Outperform $33
Aug-11-20Downgrade The Benchmark Company Buy → Hold
Jul-08-20Reiterated Maxim Group Buy $18 → $26
Feb-24-20Initiated Lake Street Buy $25
Feb-19-20Initiated The Benchmark Company Buy $24
Feb-06-20Resumed B. Riley FBR Buy $27
Jan-08-20Initiated Stephens Overweight $23
Nov-21-19Initiated Oppenheimer Outperform $22
Jul-22-19Initiated H.C. Wainwright Buy $23
Nov-10-17Reiterated Maxim Group Buy $7 → $8
Sep-19-17Reiterated Maxim Group Buy $6 → $7
Jul-05-17Upgrade Janney Neutral → Buy $5
Mar-10-17Reiterated Maxim Group Buy $3 → $4
Jan-19-17Initiated Maxim Group Buy $3
Sep-08-20 07:45AM  
Aug-25-20 05:53PM  
Aug-06-20 04:05PM  
Aug-05-20 08:38AM  
Aug-03-20 09:33AM  
Jul-30-20 05:45PM  
Jul-15-20 08:00AM  
Jul-07-20 12:45PM  
Jul-06-20 09:08AM  
06:57AM  
Jul-02-20 02:48PM  
07:40AM  
12:40AM  
Jul-01-20 04:02PM  
04:01PM  
Jun-26-20 11:45AM  
May-18-20 04:15PM  
May-14-20 08:30PM  
04:05PM  
May-13-20 12:52PM  
10:20AM  
May-11-20 08:00AM  
May-01-20 08:00AM  
Apr-20-20 06:44AM  
Mar-30-20 06:35PM  
Mar-28-20 08:45AM  
Mar-14-20 08:58AM  
08:38AM  
Mar-11-20 04:29PM  
02:30PM  
Feb-17-20 06:14AM  
Feb-12-20 08:00AM  
Feb-07-20 07:46AM  
Jan-22-20 05:46AM  
Jan-04-20 07:25AM  
Dec-30-19 11:35AM  
Dec-26-19 08:13PM  
Dec-19-19 09:26PM  
Dec-04-19 06:58AM  
Dec-02-19 08:00AM  
Nov-22-19 03:01AM  
Nov-12-19 04:03PM  
04:01PM  
Nov-11-19 08:07AM  
Nov-07-19 06:15PM  
08:00AM  
Oct-31-19 08:23PM  
Oct-22-19 09:13AM  
Oct-14-19 09:41AM  
08:00AM  
Sep-24-19 08:00AM  
08:00AM  
Sep-16-19 08:00AM  
Sep-11-19 10:15PM  
Sep-06-19 10:15PM  
Sep-03-19 12:30PM  
08:00AM  
Aug-28-19 08:00AM  
Aug-12-19 08:00AM  
Aug-08-19 11:23PM  
04:05PM  
08:05AM  
Aug-02-19 10:15PM  
Aug-01-19 10:33AM  
Jul-31-19 08:00AM  
Jul-30-19 08:00AM  
Jul-23-19 08:00AM  
Jul-08-19 04:31PM  
Jun-23-19 09:45PM  
Jun-10-19 08:00AM  
May-30-19 08:00AM  
May-29-19 08:00AM  
May-22-19 12:54PM  
May-09-19 08:24PM  
04:05PM  
May-02-19 10:32AM  
08:00AM  
Apr-02-19 08:00AM  
Mar-25-19 11:40AM  
Mar-20-19 08:08AM  
Mar-15-19 11:48PM  
Mar-14-19 08:26PM  
04:05PM  
08:00AM  
Mar-04-19 08:00AM  
Feb-19-19 08:00AM  
Feb-08-19 08:57AM  
Jan-29-19 04:10PM  
Jan-22-19 09:58AM  
08:00AM  
Jan-11-19 08:53AM  
Dec-11-18 08:00AM  
Dec-07-18 02:20PM  
Nov-27-18 08:00AM  
Nov-13-18 08:00AM  
Nov-08-18 04:05PM  
Nov-05-18 08:08AM  
08:00AM  
Nov-01-18 08:00AM  
Oct-18-18 07:40AM  
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools for the cell and gene therapy industry in North America, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; and liquid nitrogen laboratory freezers, cryogenic equipment, and accessories. The company markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was founded in 1987 and is headquartered in Bothell, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rice MichaelPresident & CEOSep 10Option Exercise2.0618,75038,625227,096Sep 10 08:00 PM
Rice MichaelPresident & CEOSep 10Sale23.2418,750435,750208,346Sep 10 08:00 PM
Rice MichaelPresident & CEOSep 08Option Exercise2.0618,75038,625227,096Sep 10 08:00 PM
Rice MichaelPresident & CEOSep 08Sale21.6418,750405,750208,346Sep 10 08:00 PM
VILLIGER WALTER10% OwnerAug 27Sale20.6121,717447,5874,821,774Aug 28 08:33 PM
Foster Karen A.Chief Quality OfficerAug 26Sale20.481793,66651,885Aug 28 08:30 PM
Mathew Aby J.Exec VP & Chief Scientific OffAug 26Sale20.482555,222187,660Aug 28 08:31 PM
Rice MichaelPresident & CEOAug 26Sale20.4887717,961208,346Aug 28 08:32 PM
VILLIGER WALTER10% OwnerAug 26Sale21.0028,283593,9434,843,491Aug 28 08:33 PM
Rice MichaelPresident & CEOAug 13Option Exercise2.0618,75038,625227,973Aug 13 08:30 PM
Rice MichaelPresident & CEOAug 13Sale18.6418,750349,500209,223Aug 13 08:30 PM
Mathew Aby J.Exec VP & Chief Scientific OffAug 12Sale19.685,00098,400187,915Aug 13 08:31 PM
Rice MichaelPresident & CEOAug 11Option Exercise2.0618,75038,625227,973Aug 13 08:30 PM
Rice MichaelPresident & CEOAug 11Sale19.9118,750373,313209,223Aug 13 08:30 PM
Mathew Aby J.Exec VP & Chief Scientific OffAug 11Sale20.0310,000200,300192,915Aug 13 08:31 PM
VILLIGER WALTER10% OwnerAug 10Sale21.6350,0001,081,5004,871,774Aug 11 08:32 PM
VILLIGER WALTER10% OwnerAug 07Sale21.0150,0001,050,5004,921,774Aug 11 08:32 PM
Rice MichaelPresident & CEOJul 16Option Exercise2.0618,75038,625232,973Jul 16 08:30 PM
Rice MichaelPresident & CEOJul 16Sale19.3018,750361,875214,223Jul 16 08:30 PM
Mathew Aby J.Exec VP & Chief Scientific OffJul 15Sale19.4810,000194,800202,915Jul 17 08:00 PM
Rice MichaelPresident & CEOJul 14Option Exercise2.0618,75038,625232,973Jul 16 08:30 PM
Rice MichaelPresident & CEOJul 14Sale18.6718,750350,063214,223Jul 16 08:30 PM
VILLIGER WALTER10% OwnerJul 06Sale18.9723,372443,3674,971,179Jul 08 09:37 PM
Casdin Partners Master Fund, L10% OwnerJul 02Buy14.50305,5834,430,9545,840,107Jul 02 04:48 PM
VILLIGER WALTER10% OwnerJul 02Sale18.5717,088317,3244,994,551Jul 08 09:37 PM
GIRSCHWEILER THOMASDirectorJul 02Sale14.50305,5834,430,9541,642,774Jul 02 06:32 PM
Casdin Partners Master Fund, L10% OwnerJul 01Buy14.50685,0009,932,5005,534,524Jul 02 04:48 PM
Rice MichaelPresident & CEOJun 19Option Exercise2.0618,75038,625232,973Jun 23 08:00 PM
Rice MichaelPresident & CEOJun 19Sale16.3718,750306,938214,223Jun 23 08:00 PM
Rice MichaelPresident & CEOJun 11Option Exercise2.0618,75038,625232,973Jun 15 08:31 PM
Rice MichaelPresident & CEOJun 11Sale15.0118,750281,438214,223Jun 15 08:31 PM
Mathers JamesChief Revenue OfficerMay 28Sale16.871212,04119,856Jun 01 08:01 PM
Foster Karen A.Chief Quality OfficerMay 28Sale16.871702,86852,064Jun 01 08:02 PM
Rice MichaelPresident & CEOMay 28Sale16.875168,705214,223Jun 01 08:00 PM
Mathew Aby J.Exec VP & Chief Scientific OffMay 28Sale16.872424,083212,915Jun 01 08:01 PM
Casdin Partners Master Fund, L10% OwnerMay 22Buy10.50476,1915,000,0064,849,524May 26 01:54 PM
GIRSCHWEILER THOMASDirectorMay 22Sale10.50476,1915,000,0061,948,357Jun 03 08:00 PM
Rice MichaelPresident & CEOMay 15Option Exercise2.0618,75038,625233,489May 15 08:05 PM
Mathew Aby J.Exec VP & Chief Scientific OffMay 15Option Exercise2.0610,00020,600223,157May 15 08:04 PM
Mathew Aby J.Exec VP & Chief Scientific OffMay 15Sale14.2910,000142,900213,157May 15 08:04 PM
Rice MichaelPresident & CEOMay 15Sale14.2318,750266,813214,739May 15 08:05 PM
Casdin Partners Master Fund, L10% OwnerMay 14Buy10.501,904,76220,000,0014,373,333May 18 04:47 PM
Rice MichaelPresident & CEOMay 13Option Exercise2.0618,75038,625233,489May 15 08:05 PM
Mathew Aby J.Exec VP & Chief Scientific OffMay 13Option Exercise2.0610,00020,600223,157May 13 08:00 PM
VILLIGER WALTER10% OwnerMay 13Sale14.90631,1589,404,2544,526,236Jun 03 08:01 PM
GIRSCHWEILER THOMASDirectorMay 13Sale14.90492,2777,334,9272,424,548Jun 03 08:00 PM
Rice MichaelPresident & CEOMay 13Sale15.4518,750289,688214,739May 15 08:05 PM
Mathew Aby J.Exec VP & Chief Scientific OffMay 13Sale15.4210,000154,200213,157May 13 08:00 PM
Mathew Aby J.Exec VP & Chief Scientific OffMay 11Option Exercise2.0610,00020,600223,157May 13 08:00 PM
Mathew Aby J.Exec VP & Chief Scientific OffMay 11Sale13.4010,000134,000213,157May 13 08:00 PM
Rice MichaelPresident & CEOApr 15Option Exercise2.0618,75038,625233,489Apr 15 08:00 PM
Rice MichaelPresident & CEOApr 15Sale9.6618,750181,125214,739Apr 15 08:00 PM
Rice MichaelPresident & CEOApr 13Option Exercise2.0618,75038,625233,489Apr 15 08:00 PM
Rice MichaelPresident & CEOApr 13Sale9.0318,750169,313214,739Apr 15 08:00 PM
Mathew Aby J.Exec VP & Chief Scientific OffMar 24Sale9.2510,00092,500179,562Mar 26 08:00 PM
Rice MichaelPresident & CEOMar 12Option Exercise2.0618,75038,625184,574Mar 12 09:25 PM
Rice MichaelPresident & CEOMar 12Sale8.4418,750158,250165,824Mar 12 09:25 PM
Rice MichaelPresident & CEOMar 10Option Exercise2.0618,75038,625184,574Mar 12 09:25 PM
Rice MichaelPresident & CEOMar 10Sale12.1618,750228,000165,824Mar 12 09:25 PM
DE GREEF RODERICKCFO & COOMar 06Option Exercise1.8110,00018,10035,859Mar 06 08:24 PM
DE GREEF RODERICKCFO & COOMar 06Sale13.7710,000137,70025,859Mar 06 08:24 PM
DE GREEF RODERICKCFO & COOMar 05Option Exercise1.8110,00018,10035,859Mar 06 08:24 PM
DE GREEF RODERICKCFO & COOMar 05Sale13.7210,000137,20025,859Mar 06 08:24 PM
DE GREEF RODERICKCFO & COOMar 04Option Exercise1.8110,00018,10035,859Mar 06 08:24 PM
DE GREEF RODERICKCFO & COOMar 04Sale13.9510,000139,50025,859Mar 06 08:24 PM
Foster Karen A.Chief Quality OfficerFeb 26Sale15.0288413,27823,701Feb 28 08:12 PM
Rice MichaelPresident & CEOFeb 26Sale15.022,19032,894165,824Feb 28 08:12 PM
Mathew Aby J.Exec VP & Chief Scientific OffFeb 26Sale15.021,02415,380189,562Feb 28 08:13 PM
Mathers JamesChief Revenue OfficerFeb 26Sale15.025087,63016,876Feb 28 08:14 PM
Rice MichaelPresident & CEOFeb 13Option Exercise2.0618,75038,625186,764Feb 13 09:36 PM
Rice MichaelPresident & CEOFeb 13Sale14.1718,750265,688168,014Feb 13 09:36 PM
Rice MichaelPresident & CEOFeb 11Option Exercise2.0618,75038,625186,764Feb 13 09:36 PM
Rice MichaelPresident & CEOFeb 11Sale13.6918,750256,688168,014Feb 13 09:36 PM
DE GREEF RODERICKCFO & COOFeb 07Option Exercise1.8110,00018,09935,859Feb 07 09:54 PM
DE GREEF RODERICKCFO & COOFeb 07Sale13.3210,000133,20025,859Feb 07 09:54 PM
DE GREEF RODERICKCFO & COOFeb 06Option Exercise1.8110,00018,09935,859Feb 07 09:54 PM
DE GREEF RODERICKCFO & COOFeb 06Sale14.4310,000144,30025,859Feb 07 09:54 PM
DE GREEF RODERICKCFO & COOFeb 05Option Exercise1.8110,00018,09935,859Feb 07 09:54 PM
Mathew Aby J.Exec VP & Chief Scientific OffFeb 05Option Exercise1.4017,96625,170200,586Feb 05 08:01 PM
DE GREEF RODERICKCFO & COOFeb 05Sale14.0610,000140,60025,859Feb 07 09:54 PM
Mathew Aby J.Exec VP & Chief Scientific OffFeb 05Sale14.0610,000140,600190,586Feb 05 08:01 PM
Mathers JamesChief Revenue OfficerFeb 04Option Exercise1.642,1133,46519,497Feb 06 08:45 PM
Mathew Aby J.Exec VP & Chief Scientific OffFeb 04Option Exercise1.4010,00014,010192,620Feb 05 08:01 PM
Mathers JamesChief Revenue OfficerFeb 04Sale14.032,11329,64517,384Feb 06 08:45 PM
Mathew Aby J.Exec VP & Chief Scientific OffFeb 04Sale14.1010,000141,000182,620Feb 05 08:01 PM
Mathew Aby J.Exec VP & Chief Scientific OffFeb 03Option Exercise1.4010,00014,010192,620Feb 05 08:01 PM
Mathew Aby J.Exec VP & Chief Scientific OffFeb 03Sale13.6310,000136,300182,620Feb 05 08:01 PM
GIRSCHWEILER THOMASDirectorJan 30Option Exercise1.4010,71415,0101,524,677Feb 03 08:39 PM
Mathers JamesChief Revenue OfficerJan 23Option Exercise1.642,5004,10019,884Jan 23 08:05 PM
Mathers JamesChief Revenue OfficerJan 23Sale15.112,50037,77517,384Jan 23 08:05 PM
Mathers JamesChief Revenue OfficerJan 22Option Exercise1.642,5004,10019,884Jan 23 08:05 PM
Mathers JamesChief Revenue OfficerJan 22Sale15.682,50039,20017,384Jan 23 08:05 PM
Mathers JamesChief Revenue OfficerJan 21Option Exercise1.642,5004,10019,884Jan 23 08:05 PM
Mathers JamesChief Revenue OfficerJan 21Sale15.692,50039,22517,384Jan 23 08:05 PM
Mathers JamesChief Revenue OfficerJan 09Option Exercise1.642,5004,10019,884Jan 09 08:01 PM
Mathers JamesChief Revenue OfficerJan 09Sale16.762,50041,90017,384Jan 09 08:01 PM
DE GREEF RODERICKCFO & COOJan 08Option Exercise1.7610,00017,60035,859Jan 08 08:00 PM
Mathers JamesChief Revenue OfficerJan 08Option Exercise1.642,5004,10019,884Jan 09 08:01 PM
DE GREEF RODERICKCFO & COOJan 08Sale16.1610,000161,60025,859Jan 08 08:00 PM
Mathers JamesChief Revenue OfficerJan 08Sale16.052,50040,12517,384Jan 09 08:01 PM